Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, August 7, 2024
[ Wed, Aug 07th 2024
] - WOPRAI
[ Wed, Aug 07th 2024
] - WOPRAI
[ Wed, Aug 07th 2024
] - WOPRAI
[ Wed, Aug 07th 2024
] - WOPRAI
[ Wed, Aug 07th 2024
] - WOPRAI
[ Wed, Aug 07th 2024
] - WOPRAI
[ Wed, Aug 07th 2024
] - WOPRAI
[ Wed, Aug 07th 2024
] - WOPRAI
[ Wed, Aug 07th 2024
] - WOPRAI
[ Wed, Aug 07th 2024
] - WOPRAI
[ Wed, Aug 07th 2024
] - WOPRAI
[ Wed, Aug 07th 2024
] - WOPRAI
[ Wed, Aug 07th 2024
] - WOPRAI
[ Wed, Aug 07th 2024
] - WOPRAI
[ Wed, Aug 07th 2024
] - WOPRAI
[ Wed, Aug 07th 2024
] - WOPRAI
[ Wed, Aug 07th 2024
] - WOPRAI
[ Wed, Aug 07th 2024
] - WOPRAI
[ Wed, Aug 07th 2024
] - WOPRAI
[ Wed, Aug 07th 2024
] - WOPRAI
[ Wed, Aug 07th 2024
] - WOPRAI
[ Wed, Aug 07th 2024
] - WOPRAI
[ Wed, Aug 07th 2024
] - WOPRAI
[ Wed, Aug 07th 2024
] - WOPRAI
[ Wed, Aug 07th 2024
] - WOPRAI
[ Wed, Aug 07th 2024
] - WOPRAI
[ Wed, Aug 07th 2024
] - WOPRAI
[ Wed, Aug 07th 2024
] - WOPRAI
[ Wed, Aug 07th 2024
] - WOPRAI
[ Wed, Aug 07th 2024
] - WOPRAI
Gena Wang Maintained (BEAM) at Hold with Decreased Target to $31 on, Aug 7th, 2024
Gena Wang of Barclays, Maintained "Beam Therapeutics Inc." (BEAM) at Hold with Decreased Target from $33 to $31 on, Aug 7th, 2024.
Gena has made no other calls on BEAM in the last 4 months.
There are 2 other peers that have a rating on BEAM. Out of the 2 peers that are also analyzing BEAM, 0 agree with Gena's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Gena
- Patrick Trucchio of "HC Wainwright & Co." Initiated at Strong Buy and Held Target at $80 on, Tuesday, July 23rd, 2024
- David Nierengarten of "Wedbush" Reiterated at Buy and Held Target at $57 on, Tuesday, April 23rd, 2024
